1. LY2109761, a novel transforming growth factor β receptor type I and type II dual inhibitor, as a therapeutic approach to suppressing pancreatic cancer metastasis
   Davide Melisi et al, 2008, Molecular Cancer Therapeutics CrossRef
2. Targeting Endogenous Transforming Growth Factor β Receptor Signaling in SMAD4-Deficient Human Pancreatic Carcinoma Cells Inhibits Their Invasive Phenotype
   Gayathri Subramanian et al, 2004, Cancer Research CrossRef
3. Activation of Peroxisome Proliferator-Activated Receptor-γ Decreases Pancreatic Cancer Cell Invasion through Modulation of the Plasminogen Activator System
   Hirozumi Sawai et al, 2006, Molecular Cancer Research CrossRef
4. An Extensive Review on Preclinical and Clinical Trials of Oncolytic Viruses Therapy for Pancreatic Cancer
   Maryum Nisar et al, 2022, Frontiers in Oncology CrossRef
5. Human Surfactant Protein D Suppresses Epithelial-to-Mesenchymal Transition in Pancreatic Cancer Cells by Downregulating TGF-β
   Anuvinder Kaur et al, 2018, Frontiers in Immunology CrossRef
6. N-Cadherin Expression and Epithelial-Mesenchymal Transition in Pancreatic Carcinoma
   Sanae Nakajima et al, 2004, Clinical Cancer Research CrossRef
7. Extracellular Matrix–Mediated Membrane-Type 1 Matrix Metalloproteinase Expression in Pancreatic Ductal Cells Is Regulated by Transforming Growth Factor-β1
   Adam J. Ottaviano et al, 2006, Cancer Research CrossRef
8. Applications of Biosurfactants in Various Cancer Therapies
   Twinkle Rout et al, 2024, Biosurfactants: A Boon to Healthcare, Agriculture & Environmental Sustainability CrossRef